SCARB2/LIMP2 deficiency in action myoclonus-renal failure syndrome
Date
2016
Authors
Dibbens, L.
Schwake, M.
Saftig, P.
Rubboli, G.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Epileptic Disorders, 2016; 18(S2):S63-S72
Statement of Responsibility
Conference Name
Abstract
Action myoclonus–renal failure syndrome (AMRF) is an autosomal recessive progressive myoclonus epilepsy (PME) associated with renal dysfunction that appears in the second or third decade of life and that is caused by loss-of-function mutations in the SCARB2 gene encoding lysosomal integral membrane protein type 2 (LIMP2). Recent reports have documented cases with PME associated with SCARB2 mutations without renal compromise. Additional neurological features can be demyelinating peripheral neuropathy, hearing loss and dementia. The course of the disease in relentlessly progressive. In this paper we provide an updated overview of the clinical and genetic features of SCARB2-related PME and on the functions of the LIMP2 protein.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2017 John Libbey Eurotext